GlassScriptPhysician profile
William Sidney Barnes
NPI 1972543973
$3,892.99
in general payments reported to CMS, 2019-2025
25 companies · $24.73 in 2025
The $24.73 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,973 · 2020: $734 · 2021: $624 · 2022: $206 · 2023: $197 · 2024: $134 · 2025: $24.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $1,044.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $824.43 | 2019-2021 | |
| Stryker Corporation | $678.78 | 2019-2021 | |
| Conformis, INC. | $461.99 | 2019 | |
| Medacta USA, INC. | $203.49 | 2022-2023 | Gmk Sphere |
| Djo, LLC | $113.43 | 2023 | Cmf |
| Medtronic USA, INC. | $102.70 | 2020 | |
| Ermi LLC | $69.05 | 2023-2024 | |
| Amgen INC. | $65.39 | 2021-2025 | Krystexxa |
| Smith+Nephew, INC. | $38.39 | 2019-2020 | |
| Depuy Synthes Sales INC. | $36.54 | 2019-2021 | |
| Horizon Therapeutics Plc | $28.30 | 2020-2021 | |
| Fidia Pharma USA INC. | $24.19 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $23.61 | 2024 | Zilretta, Iovera, Exparel |
| Dynasplint Systems INC. | $21.38 | 2024 | Dynasplint |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.79 | 2024 | |
| Kci USA, INC. | $19.38 | 2021 | |
| Ferring Pharmaceuticals INC. | $19.01 | 2022 | |
| Orthogenrx INC. | $18.96 | 2020 | |
| Radius Health, INC. | $14.77 | 2021 | |
| Tactile Systems Technology INC | $14.12 | 2024 | Flexitouch Plus, Entre Plus |
| Heraeus Medical, LLC. | $13.68 | 2022 | |
| Vericel Corporation | $13.34 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.31 | 2022 | |
| Bioventus LLC | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.